Clinical Trials Browser

Leiomyosarcoma × Doxorubicin × 30 days × Clear all

NCT05711615 2026-05-15

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Phase 1 Recruiting

Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT06088290 2026-05-15

SaLuDo

Phase 3 Active not recruiting

Leiomyosarcoma, Neoplasms